financetom
Business
financetom
/
Business
/
ADM cuts 2025 profit outlook on weaker crush margins
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ADM cuts 2025 profit outlook on weaker crush margins
Nov 4, 2025 3:34 AM

(Reuters) -Archer-Daniels-Midland Co ( ADM ) on Tuesday lowered its full-year 2025 earnings forecast, citing weaker crush margins and a delay in U.S. biofuel policy, sending the grain trader's shares down 8.5% in premarket trading.

ADM now expects adjusted earnings of $3.25 to $3.50 per share for 2025, down from its earlier forecast of around $4.00. However, the company said it sees policy clarity and improving global trade flows supporting growth in 2026.

The company posted an adjusted profit of 92 cents per share for the three months ended September 30, beating average estimate of 85 cents, according to data compiled by LSEG.

ADM's outlook underscores how the world's biggest agricultural processors are being squeezed by volatile biofuel policies and soft global trade flows, even as steady ethanol demand and cost discipline help cushion profits.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Poet Technologies Combines Optical Engine With InSiGa's EML Driver
Poet Technologies Combines Optical Engine With InSiGa's EML Driver
Sep 11, 2024
08:15 AM EDT, 09/11/2024 (MT Newswires) -- Poet Technologies ( POET ) and Chengdu InSiGa Semiconductor Technologies said Wednesday they have developed a solution for 200Gx4 applications using Poet's 200Gx4 transmit optical engine and InSiGa's 200G/lane EML driver ISG-D9616 for 800G and 1.6T modules. The companies will showcase the new product at the China International Optoelectronic Expo until Friday, Poet...
Eupraxia Pharmaceuticals Reports Positive Data from RESOLVE Trial
Eupraxia Pharmaceuticals Reports Positive Data from RESOLVE Trial
Sep 11, 2024
08:15 AM EDT, 09/11/2024 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) on Wednesday announced additional positive clinical data from its RESOLVE Phase 1b/2a trial, which is evaluating the safety and efficacy of EP-104GI as a treatment for eosinophilic esophagitis (EoE), an allergic condition that causes the esophagus to be inflamed and not contract properly. The results from the fourth...
Sun Life Announces Leadership Changes for Sun Life Canada
Sun Life Announces Leadership Changes for Sun Life Canada
Sep 11, 2024
08:21 AM EDT, 09/11/2024 (MT Newswires) -- Sun Life (SLF.TO, SLF) on Wednesday said Jacques Goulet has been named executive chair of Sun Life Canada while Jessica Tan succeeds him as president of Sun Life Canada. The two will assume their new positions on September 30. Goulet, who joined Sun Life in 2018, will also continue as the chair of...
BriaCell Reports Positive Data for Bria-IMT in Phase 2 Metastatic Breast Cancer Study - Shares Soar Premarket
BriaCell Reports Positive Data for Bria-IMT in Phase 2 Metastatic Breast Cancer Study - Shares Soar Premarket
Sep 11, 2024
08:19 AM EDT, 09/11/2024 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) said Wednesday it yielded positive overall survival data in a phase 2 late-stage metastatic breast cancer study evaluating Bria-IMT in combination with an immune check point inhibitor. The 54-patient study showed median survival of 15.6 months in patients treated with Bria-MT compared with 6.7 to 9.3 months for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved